Cargando…

Role of cytotoxic T cells and PD-1 immune checkpoint pathway in papillary thyroid carcinoma

BACKGROUND: Lymphocytic thyroiditis (LT) is frequently seen in the tumor microenvironment (TME) of papillary thyroid carcinomas (PTCs). However, the characteristic of these tumor-infiltrating lymphocytes (TILs) is not well understood. OBJECTIVE: We aim to define the TME of PTC cases by characterizin...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerjee, Sohini, Nahar, Uma, Dahiya, Divya, Mukherjee, Soham, Dey, Pranab, Gupta, Rijuneeta, Radotra, Bishan, Sachdeva, Naresh, Sood, Ashwani, Bhadada, Sanjay Kumar, Bhansali, Anil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742369/
https://www.ncbi.nlm.nih.gov/pubmed/36518249
http://dx.doi.org/10.3389/fendo.2022.931647
Descripción
Sumario:BACKGROUND: Lymphocytic thyroiditis (LT) is frequently seen in the tumor microenvironment (TME) of papillary thyroid carcinomas (PTCs). However, the characteristic of these tumor-infiltrating lymphocytes (TILs) is not well understood. OBJECTIVE: We aim to define the TME of PTC cases by characterizing the TILs. DESIGN: This is a cross-sectional observational study. PATIENTS: We enrolled 29 PTC (23 having concurrent LT), 14 LT, and 13 hyperplastic nodules with LT (HN) patients from January 2016 to December 2020. MEASUREMENTS: Immunohistochemical (IHC) expression of CD8, FoxP3, PD-1, and PD-L1 was studied in PTC with LT and compared with HN. PD-1 and PD-L1 expression was correlated at the mRNA level by quantitative real-time PCR. Immunophenotyping of TILs was done in FNAC samples of PTC and LT by flow cytometry. RESULTS: IHC revealed the presence of CD8(+) cytotoxic T lymphocytes (CTLs) and FoxP3(+) T regulatory cells (Tregs) in 83% and 52% of PTC with LT cases, respectively. Flow cytometric analysis of the PTC samples revealed a significant abundance of CTL compared with Treg and a higher CTL with lower Treg counts compared with LT. On IHC, PD-1 positivity was noted in 56.5% of PTC with LT cases, while intermediate PD-L1 positivity was found in 70% of the cases. There was a significant upregulation of PD-1 mRNA in PTC with LT. A significant correlation was noted with PD-L1 expression with lymph node metastasis and presence of Treg cells. CONCLUSIONS: Increased expression of PD-1 and PD-L1 in the TME of PTC may provide a potential molecular mechanism for tumor survival despite the predominance of CTLs, possibly through their inactivation or exhaustion.